InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Jennifer Lachey, Chief Scientific Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 14 open-market SEC Form 4 transactions: 0 purchases worth $0 and 14 sales worth $4.4M, reported from Nov 4, 21 to Jul 15, 22. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 22 | KROSKeros Therapeutics, Inc. | SELL | 46.0K | $30.00 | $1.4M |
| Jul 13, 22 | KROSKeros Therapeutics, Inc. | SELL | 1.9K | $30.00 | $57K |
| May 11, 22 | KROSKeros Therapeutics, Inc. | SELL | 3.4K | $45.45 | $140K |
| Apr 11, 22 | KROSKeros Therapeutics, Inc. | SELL | 2.3K | $64.15 | $147K |
| Apr 4, 22 | KROSKeros Therapeutics, Inc. | SELL | 8.0K | $60.00 | $477K |
| Mar 11, 22 | KROSKeros Therapeutics, Inc. | SELL | 1.1K | $54.54 | $56K |
| Feb 11, 22 | KROSKeros Therapeutics, Inc. | SELL | 1.4K | $53.10 | $72K |
| Jan 11, 22 | KROSKeros Therapeutics, Inc. | SELL | 1.2K | $54.45 | $64K |
| Jan 5, 22 | KROSKeros Therapeutics, Inc. | SELL | 2.6K | $60.00 | $159K |
| Dec 15, 21 | KROSKeros Therapeutics, Inc. | SELL | 735 | $50.00 | $37K |
| Dec 13, 21 | KROSKeros Therapeutics, Inc. | SELL | 1.5K | $53.64 | $76K |
| Nov 11, 21 | KROSKeros Therapeutics, Inc. | SELL | 4.6K | $59.78 | $273K |
| Nov 10, 21 | KROSKeros Therapeutics, Inc. | SELL | 15.9K | $60.00 | $954K |
| Nov 4, 21 | KROSKeros Therapeutics, Inc. | SELL | 10.6K | $50.00 | $530K |